The Board granted service connection for acute myelogenous leukemia (AML) based on the Veteran's exposure to herbicide agents during his service in Vietnam.
The deciding factor: The Veteran's AML is related to exposure to herbicide agents during service, as evidenced by medical records and a VA examination.
- Claimed conditions
- acute myelogenous leukemia (AML)
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- None in this decision
- Decision date
- March 18, 2025
- Citation
- A25024730
Veterans Law Judge
Decisions by this judge: 907 · Granted: 35% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25024730.
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Remanded (sent back)
The Board remands the claims for further development, specifically to obtain a medical opinion addressing the Veteran's claimed exposure to benzene and other toxic substances during service.
- Remanded (sent back)
The Board remands the claims for service connection for the cause of the Veteran's death and DIC under 38 U.S.C. § 1318 due to an inadequate medical opinion and a need for additional development regarding potential exposures during service.
- Granted
The Board has granted service connection for chronic myelomonocytic leukemia (CMML) and acute myelogenous leukemia (AML), finding that both conditions are related to the Veteran's exposure to herbicides during service.
- Remanded (sent back)
The Board has remanded the claims for chloracne, colon cancer, Parkinson's disease, Hodgkin's lymphoma, left upper extremity peripheral neuropathy (secondary to Hodgkin's lymphoma), right upper extremity peripheral neuropathy (secondary to Hodgkin's lymphoma), left lower extremity peripheral neuropathy (secondary to Hodgkin's lymphoma treatment), and right lower extremity peripheral neuropathy (secondary to Hodgkin's lymphoma treatment).,The Board has also remanded the claim for rhabdomyolysis and AML.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.